UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

COVID‐19 infection and vaccination in patients with Skeletal Muscle Channelopathies

Vivekanandam, Vinojini; Jayaseelan, Dipa; Hanna, Michael G; (2022) COVID‐19 infection and vaccination in patients with Skeletal Muscle Channelopathies. Muscle & Nerve , 66 (5) pp. 617-620. 10.1002/mus.27704. Green open access

[thumbnail of Vivekanandam_Muscle and Nerve - 2022 - Vivekanandam - COVID‐19 infection and vaccination in patients with skeletal muscle.pdf]
Preview
Text
Vivekanandam_Muscle and Nerve - 2022 - Vivekanandam - COVID‐19 infection and vaccination in patients with skeletal muscle.pdf

Download (582kB) | Preview

Abstract

Introduction/Aims: Although we have gained insight into coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome–coronavirus 2 since the beginning of the pandemic, our understanding of the consequences for patients with neuromuscular disorders is evolving. In this study we aimed to study the impact of COVID-19 and COVID-19 vaccination on skeletal muscle channelopathies. Methods: We conducted a survey of patients with genetically confirmed skeletal muscle channelopathies seen at the UK Nationally Commissioned Channelopathy Service. Results: Thirty-eight patient responses were received. Six patients had COVID-19 infection leading to exacerbation of their underlying muscle channelopathy. No major complications were reported. Thirty-six patients had received one or two COVID-19 vaccinations and the majority (68%) had no worsening of their underlying channelopathy. Thirty-two percent reported worsening of their usual symptoms of their muscle channelopathy, but all reported recovery to baseline levels. No serious adverse events were reported. Discussion: The overall rates of COVID-19 infection were low in our study and COVID-19 vaccine uptake rates were high. Our results have been useful to inform patients that a subset of patients have reversible worsening of their channelopathy post–COVID-19 vaccination. Our study provides information for giving advice to patients with skeletal muscle channelopathies regarding COVID-19 infection and vaccination.

Type: Article
Title: COVID‐19 infection and vaccination in patients with Skeletal Muscle Channelopathies
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/mus.27704
Publisher version: https://doi.org/10.1002/mus.27704
Language: English
Additional information: © 2022 The Authors. Muscle & Nerve published by Wiley Periodicals LLC. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Keywords: channelopathies, coronavirus, COVID-19, myotonia, neuromuscular disorders
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Department of Neuromuscular Diseases
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
URI: https://discovery.ucl.ac.uk/id/eprint/10154307
Downloads since deposit
55Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item